Insmed
INSM
#655
Rank
S$45.82 B
Marketcap
S$214.84
Share price
-16.08%
Change (1 day)
115.59%
Change (1 year)

Insmed (INSM) - P/B ratio

P/B ratio as of December 2025 : 37.5

According to Insmed's latest financial reports the company has a price-to-book ratio of 79.289.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Insmed - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-3144.41.83%
2024-12-3143.6-426.71%
2023-12-31-13.4-143.4%
2022-12-3130.8291.78%
2021-12-317.86-36.09%
2020-12-3112.350.19%
2019-12-318.1868.05%
2018-12-314.87-26.37%
2017-12-316.6124.81%
2016-12-315.3047.23%
2015-12-313.60-13%
2014-12-314.14-10.88%
2013-12-314.64166.39%
2012-12-311.74208.92%
2011-12-310.564110.17%
2010-12-310.5120-36.72%
2009-12-310.8091-103.99%
2008-12-31-20.3-331.38%
2007-12-318.7536.27%
2006-12-316.42-48.39%
2005-12-3112.4-8.78%
2004-12-3113.6213.74%
2003-12-314.35584.38%
2002-12-310.6355

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Sarepta Therapeutics
SRPT
1.63-95.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5.79-84.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
7.05-81.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
3.36-91.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
6.64-82.29%๐Ÿ‡บ๐Ÿ‡ธ USA